Condition
EGFR Positive Non-small Cell Lung Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 4 EGFR Positive Non-small Cell Lung Cancer clinical trials that are recruiting, at sites in 3 countries (most in China (2), United States (1), Singapore (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest EGFR Positive Non-small Cell Lung Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Firmonertinib given before surgery for EGFR-mutated NSCLC | Phase 2 | Beijing | Recruiting | Jun 3, 2026 |
| Osimertinib plus savolitinib for EGFR-mutated lung cancer with low-level MET amplification | Phase 2 | Qingdao | Recruiting | Jan 7, 2026 |
| Using Osimertinib for treating advanced EGFR-positive lung cancer | — | Singapore | Recruiting | Sep 8, 2021 |
| Supportive care model for patients with advanced lung cancer | — | Boston, Massachusetts | Recruiting | May 25, 2021 |
All recruiting trials (4)
-
Firmonertinib given before surgery for EGFR-mutated NSCLC
This study tests whether taking firmonertinib before and around surgery helps patients with resectable EGFR-mutated NSCLC see more tumor shrinkage before the operation.
-
Osimertinib plus savolitinib for EGFR-mutated lung cancer with low-level MET amplification
This trial tests whether adding savolitinib to osimertinib helps people with EGFR-mutant non-small cell lung cancer who became resistant to osimertinib and have low-level MET amplification.
-
Using Osimertinib for treating advanced EGFR-positive lung cancer
This study is testing if the oral medication Osimertinib can help people with advanced EGFR-positive lung cancer who haven't had treatment before feel better and live longer.
-
Supportive care model for patients with advanced lung cancer
This study is testing a new supportive care program for people with advanced lung cancer to see if it helps them feel less stressed and more confident about managing their condition compared to standard care.
Related topics
Quick answers
How many EGFR Positive Non-small Cell Lung Cancer clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), United States (1 trial), Singapore (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.